Xiaobing Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiaobing Huang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Bin Tang
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
1 shared publication - Chuanjian Lu
State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
1 shared publication - Haiming Chen
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China
1 shared publication - Haixin Zhong
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
1 shared publication - Kexin Yang
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
1 shared publication - Ling Han
The Second Clinical Medical College of Guangzhou, University of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 12 December 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (12) , 1586
The Role of Extracellular Vesicles in the Development and Treatment of Psoriasis: Narrative Review
Psoriasis is a chronic inflammatory polygenic disease with significant impacts on skin and joints, leading to substantial treatment challenges and healthcare costs. The quest for novel therapeutic avenues has recently highlighted extracellular vesicles (EVs) due to their potential as biomarkers and therapeutic agents in autoimmune diseases, including psoriasis. EVs are nano-sized, lipid membrane-bound particles secreted by cells that have emerged as promising tools for targeted drug delivery, owing to their unique structure. This review delves into how EVs, either as mediators of cell communication or via their cargo (such as miRNA), directly participate in the pathology of psoriasis, influencing processes such as immune regulation, cell proliferation, and differentiation. Furthermore, this review explores the innovative application of EVs in psoriasis treatment, both as direct therapeutic agents and as vehicles for drug delivery, offering a novel approach to overcoming the current treatment limitations.
- 12 December 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (12) , 1586
Open AccessThe Role of Extracellular Vesicles in the Development and Treatment of Psoriasis: Narrative Review
Psoriasis is a chronic inflammatory polygenic disease with significant impacts on skin and joints, leading to substantial treatment challenges and healthcare costs. The quest for novel therapeutic avenues has recently highlighted extracellular vesicles (EVs) due to their potential as biomarkers and therapeutic agents in autoimmune diseases, including psoriasis. EVs are nano-sized, lipid membrane-bound particles secreted by cells that have emerged as promising tools for targeted drug delivery, owing to their unique structure. This review delves into how EVs, either as mediators of cell communication or via their cargo (such as miRNA), directly participate in the pathology of psoriasis, influencing processes such as immune regulation, cell proliferation, and differentiation. Furthermore, this review explores the innovative application of EVs in psoriasis treatment, both as direct therapeutic agents and as vehicles for drug delivery, offering a novel approach to overcoming the current treatment limitations.